[
  {
    "ts": null,
    "headline": "Regeneron Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors",
    "summary": "Regeneron Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=2644a0d16d3da60811d46a4a17b0a4484345229bb12bd30613f75ff99dec691c",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760633160,
      "headline": "Regeneron Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors",
      "id": 137143494,
      "image": "",
      "related": "REGN",
      "source": "MarketWatch",
      "summary": "Regeneron Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=2644a0d16d3da60811d46a4a17b0a4484345229bb12bd30613f75ff99dec691c"
    }
  },
  {
    "ts": null,
    "headline": "REGN Reports Encouraging Data on Gene Therapy for Genetic Hearing Loss (Revised)",
    "summary": "Regeneron's DB-OTO gene therapy shows hearing gains in nearly all CHORD study participants, with durable and meaningful improvements.",
    "url": "https://finnhub.io/api/news?id=dad9fe6a566a7d1539cb8c6528a056a2374f0616be72adf0bebca21baa161a45",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760597640,
      "headline": "REGN Reports Encouraging Data on Gene Therapy for Genetic Hearing Loss (Revised)",
      "id": 137102961,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "Regeneron's DB-OTO gene therapy shows hearing gains in nearly all CHORD study participants, with durable and meaningful improvements.",
      "url": "https://finnhub.io/api/news?id=dad9fe6a566a7d1539cb8c6528a056a2374f0616be72adf0bebca21baa161a45"
    }
  }
]